Skip to content

SDOCT-GMPE Software

A Prospective Evaluation of the Novel Glaucoma Premium Edition Software for Spectral Domain Optical Coherence Tomography

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02235454
Enrollment
57
Registered
2014-09-10
Start date
2014-11-30
Completion date
2016-08-01
Last updated
2017-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

glaucoma, OCT, spectral domain optical coherence tomography

Brief summary

The investigators prospectively evaluate the new glaucoma premium edition (GMPE) software for spectral domain optical coherence tomography (SDOCT) and if this software is superior to the conventional one that is currently used for SDOCT.

Detailed description

The new GMPE software can now identify the ocular structures without input from the operator thus reducing operator induced errors. It also measures the thickness of the entire optic nerve head so as to allow for another anatomic area of the eye to be measured for assessment of glaucoma. In addition, it permits collection of retinal nerve fiber layer thickness data in three concentric circles instead of just one in order to account for different sizes of optic nerves. Subjects who are receiving routine SDOCT (CPT 92133) will be recruited from the Duke Eye Center and its associated satellite clinics. Following informed consent, subjects undergo additional imaging using the SDOCT-GMPE software at the Duke Eye Center and its associated satellite clinics. The imaging results may be used in clinical care for the subjects.

Interventions

DEVICESDOCT-GMPE software

Noninvasive imaging of the optic nerve in patients with existing glaucoma

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* capable and willing to provide consent * history of clinically-diagnosed glaucoma * at least 18 years of age

Exclusion criteria

* unable or unwilling to give consent * under 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Retinal Nerve Fiber Layer (RNFL) Thickness Correlation Width Global Bruch's Membrane Opening-minimum Rim Width (BMO-MRW)imaging approximately 10 minutesPearson correlation coefficient between Retinal Nerve Fiber Layer (RNFL) thickness correlation width global Bruch's membrane opening-minimum rim width (BMO-MRW).

Countries

United States

Participant flow

Participants by arm

ArmCount
Glaucoma Arm
Consecutive patients with glaucoma will undergo non-invasive OCT imaging SDOCT-GMPE software: Noninvasive imaging of the optic nerve in patients with existing glaucoma
55
Total55

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicGlaucoma Arm
Age, Continuous59.5 years
STANDARD_DEVIATION 13
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
7 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
39 Participants
Region of Enrollment
United States
55 participants
Sex: Female, Male
Female
25 Participants
Sex: Female, Male
Male
30 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 55
serious
Total, serious adverse events
0 / 55

Outcome results

Primary

Retinal Nerve Fiber Layer (RNFL) Thickness Correlation Width Global Bruch's Membrane Opening-minimum Rim Width (BMO-MRW)

Pearson correlation coefficient between Retinal Nerve Fiber Layer (RNFL) thickness correlation width global Bruch's membrane opening-minimum rim width (BMO-MRW).

Time frame: imaging approximately 10 minutes

Population: All usable images of one eye of each participant

ArmMeasureValue (NUMBER)
Glaucoma ArmRetinal Nerve Fiber Layer (RNFL) Thickness Correlation Width Global Bruch's Membrane Opening-minimum Rim Width (BMO-MRW)0.70 correlation coefficient

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026